Company profile: ScienceIO
1.1 - Company Overview
Company description
- Provider of a biomedical language platform and AI solutions that transform complex medical text into usable data and insights, detecting biomedical terms, clinical variables, and codes, linking concepts for powerful queries. Offers API access, patient cohorting, digital health message analysis, commercial landscaping, payor workflow digitization, and diagnostics & biomarkers for genomic-driven patient segmentation.
Products and services
- Diagnostics & Biomarkers: A genomics-aware product that identifies complex biomarkers and segments patients for optimized care using genomic information, connecting medical concepts to enable powerful queries across complex medical text
- API Access: A modular interface supplying tools for developers to integrate ScienceIO into applications, enabling detection and extraction of biomedical terms, clinical variables, and medical codes for data and queries
- Patient Cohorting: An AI-driven system that selects patient cohorts from unstructured data like diagnoses and test results, connecting medical concepts to perform queries that identify clinically relevant groups
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ScienceIO
Medable
HQ: United States
Website
- Description: Provider of a global decentralized clinical trial platform powered by patient-generated data that streamlines design, recruitment, retention, and data quality, replaces siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution, and connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medable company profile →
Mednet
HQ: United States
Website
- Description: Provider of eClinical solutions for the global life science community, specializing in their design within the healthcare sector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mednet company profile →
Buzzumi
HQ: United Kingdom
Website
- Description: Provider of a video platform enabling experts, bloggers, and analysts to monetize online communities through easy live paid video chats and webinars, with instant creation and customization, no upfront fees or downloads, and pay-as-you-use pricing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Buzzumi company profile →
GenoLogics
HQ: Canada
Website
- Description: Provider of discovery and biomedical solutions and collaborative data management software for life sciences research, deployable across multiple labs to support translational medicine and systems biology, advancing early detection, prevention, and treatment of disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenoLogics company profile →
Benchling
HQ: United States
Website
- Description: Provider of a cloud-based platform for biology researchers and R&D organizations, including the Benchling R&D Cloud to centralize and standardize scientific data, enable collaboration, and provide insights; Benchling Bioresearch to design and manage experiments, biomolecules, workflows, and results; Benchling Notebook; plus CRISPR guide RNA design and sequence alignment tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Benchling company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ScienceIO
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ScienceIO
2.2 - Growth funds investing in similar companies to ScienceIO
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ScienceIO
4.2 - Public trading comparable groups for ScienceIO
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →